ES2963112T3 - Compuestos de imidazoquinolina y usos de los mismos - Google Patents

Compuestos de imidazoquinolina y usos de los mismos Download PDF

Info

Publication number
ES2963112T3
ES2963112T3 ES19858183T ES19858183T ES2963112T3 ES 2963112 T3 ES2963112 T3 ES 2963112T3 ES 19858183 T ES19858183 T ES 19858183T ES 19858183 T ES19858183 T ES 19858183T ES 2963112 T3 ES2963112 T3 ES 2963112T3
Authority
ES
Spain
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
cancer
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES19858183T
Other languages
English (en)
Spanish (es)
Inventor
Lihu Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Birdie Biopharmaceuticals Inc
Original Assignee
Birdie Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Birdie Biopharmaceuticals Inc filed Critical Birdie Biopharmaceuticals Inc
Application granted granted Critical
Publication of ES2963112T3 publication Critical patent/ES2963112T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES19858183T 2018-09-07 2019-09-05 Compuestos de imidazoquinolina y usos de los mismos Active ES2963112T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862728556P 2018-09-07 2018-09-07
PCT/US2019/049784 WO2020051356A1 (en) 2018-09-07 2019-09-05 Imidazoquinoline compounds and uses thereof

Publications (1)

Publication Number Publication Date
ES2963112T3 true ES2963112T3 (es) 2024-03-25

Family

ID=69722888

Family Applications (1)

Application Number Title Priority Date Filing Date
ES19858183T Active ES2963112T3 (es) 2018-09-07 2019-09-05 Compuestos de imidazoquinolina y usos de los mismos

Country Status (9)

Country Link
US (1) US20210214354A1 (cg-RX-API-DMAC7.html)
EP (2) EP4306523A3 (cg-RX-API-DMAC7.html)
JP (1) JP2022501327A (cg-RX-API-DMAC7.html)
KR (1) KR20210074290A (cg-RX-API-DMAC7.html)
CN (1) CN113164460A (cg-RX-API-DMAC7.html)
AU (1) AU2019335366A1 (cg-RX-API-DMAC7.html)
CA (1) CA3111786A1 (cg-RX-API-DMAC7.html)
ES (1) ES2963112T3 (cg-RX-API-DMAC7.html)
WO (1) WO2020051356A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3092256B1 (en) 2014-01-10 2022-05-18 Birdie Biopharmaceuticals Inc. Compounds and compositions for immunotherapy
DK4001311T3 (da) 2014-07-09 2026-02-02 Birdie Biopharmaceuticals Inc Anti-pd-l1/pd-1-kombinationer til behandling af tumorer
CN112546238A (zh) 2014-09-01 2021-03-26 博笛生物科技有限公司 用于治疗肿瘤的抗-pd-l1结合物
CN106943596A (zh) 2016-01-07 2017-07-14 博笛生物科技(北京)有限公司 用于治疗肿瘤的抗-cd20组合
CN106943597A (zh) 2016-01-07 2017-07-14 博笛生物科技(北京)有限公司 用于治疗肿瘤的抗-egfr组合
CN106943598A (zh) 2016-01-07 2017-07-14 博笛生物科技(北京)有限公司 用于治疗肿瘤的抗-her2组合
BR112019000071A2 (pt) 2016-07-07 2019-07-02 Bolt Biotherapeutics Inc conjugados adjuvantes de anticorpo
CN108794467A (zh) 2017-04-27 2018-11-13 博笛生物科技有限公司 2-氨基-喹啉衍生物
FI3641771T3 (fi) 2017-06-23 2026-08-11 Birdie Biopharmaceuticals Inc Farmaseuttisia koostumuksia
EP3937984A1 (en) 2019-03-15 2022-01-19 Bolt Biotherapeutics, Inc. Immunoconjugates targeting her2
BR112022008039A2 (pt) * 2019-10-29 2022-07-12 Prime Reach Trading Ltd Compostos de 4-amino-imidazoquinolina e usos relacionados
AU2021305193A1 (en) * 2020-07-08 2023-02-09 Purdue Research Foundation Compounds, compositions, and methods for the treatment of fibrotic diseases and cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US689338A (en) * 1901-03-29 1901-12-17 Nat Faucet Company Tapping-bung.
US5389640A (en) * 1991-03-01 1995-02-14 Minnesota Mining And Manufacturing Company 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
EP1667694B1 (en) * 2003-09-05 2010-04-28 Anadys Pharmaceuticals, Inc. Tlr7 ligands for the treatment of hepatitis c
AU2005284835A1 (en) * 2004-09-14 2006-03-23 Novartis Vaccines And Diagnostics Inc. Imidazoquinoline compounds
US8728486B2 (en) * 2011-05-18 2014-05-20 University Of Kansas Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
US9034336B2 (en) * 2011-08-30 2015-05-19 Regents Of The University Of Minnesota Immunomodulators and immunomodulator conjugates
ES2804101T3 (es) * 2014-04-22 2021-02-03 Hoffmann La Roche Compuestos de 4-amino-imidazoquinolina
DK4001311T3 (da) * 2014-07-09 2026-02-02 Birdie Biopharmaceuticals Inc Anti-pd-l1/pd-1-kombinationer til behandling af tumorer
CN112546230A (zh) * 2014-07-09 2021-03-26 博笛生物科技有限公司 用于治疗癌症的联合治疗组合物和联合治疗方法
CN105732635A (zh) * 2014-12-29 2016-07-06 南京明德新药研发股份有限公司 一类Toll样受体7激动剂
CN106943598A (zh) * 2016-01-07 2017-07-14 博笛生物科技(北京)有限公司 用于治疗肿瘤的抗-her2组合

Also Published As

Publication number Publication date
US20210214354A1 (en) 2021-07-15
AU2019335366A1 (en) 2021-03-25
KR20210074290A (ko) 2021-06-21
CN113164460A (zh) 2021-07-23
CA3111786A1 (en) 2020-03-12
EP3846807A4 (en) 2022-05-18
JP2022501327A (ja) 2022-01-06
EP4306523A2 (en) 2024-01-17
EP3846807A1 (en) 2021-07-14
WO2020051356A1 (en) 2020-03-12
EP3846807B1 (en) 2023-08-02
EP4306523A3 (en) 2024-01-24

Similar Documents

Publication Publication Date Title
EP3846807B1 (en) Imidazoquinoline compounds and uses thereof
ES2858753T3 (es) Derivados de 6-oxo-N-(1-(bencil)-1H-pirazol-4-il)-6,7,8,9-tetrahidropirido[3',2':4,5]pirrolo[1,2-a]pirazin-2-carboxamida como inhibidores de cinasa S6 ribosómica (RSK) p90 para el tratamiento del cáncer
ES3030010T3 (en) Heterocyclic compounds as immunomodulators
ES2943028T3 (es) Derivados de tetrahidro-imidazo[4,5-c]piridina como inmunomoduladores de PD-L1
ES2716811T3 (es) Derivados piperidinopirimidínicos para el tratamiento de infecciones víricas
US10125133B2 (en) Substituted [1,2,4]triazolo[1,5-a]pyridines and substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors
ES2940611T3 (es) Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad de NLRP
ES2804101T3 (es) Compuestos de 4-amino-imidazoquinolina
TWI652269B (zh) 氮雜吡啶酮化合物及其用途
ES2949660T3 (es) Procedimiento para la preparación de compuestos útiles para tratar la atrofia muscular espinal
ES2578735T3 (es) Isotiazolopiridinonas útiles para el tratamiento de (entre otros) fibrosis quística
JP2022105091A (ja) cGASアンタゴニスト化合物
ES2707885T3 (es) Alquilpirimidinderivados para el tratamiento de infecciones víricas y otras enfermedades
ES2935012T3 (es) Compuesto de difenilaminopirimidina y triazina, y composición farmacéutica y uso del mismo
ES3028360T3 (en) Deuterated n-benzenesulfonylbenzamide compound for inhibiting bcl-2 protein and composition and use thereof
US20220251097A1 (en) Molecules and methods related to treatment of uncontrolled cellular proliferation
US20190343814A1 (en) Pyrazolopyridine compounds and uses thereof
KR20160128416A (ko) 아미드 화합물, 그의 제조방법, 및 rna 함유 및/또는 dna 함유 바이러스에 의해 유발된 질환, 및 동반 질환의 예방 및 치료제로서의 용도
WO2022111636A1 (zh) 稠合三环化合物、其制备方法及其在医药上的应用
WO2022022489A1 (zh) 吲哚稠环类衍生物、其制备方法及其在医药上的应用
ES2743183T3 (es) Derivados de piridopirimidinodiona como supresores de mutaciones finalizadoras
ES2963696T3 (es) Compuestos diméricos de indol sustituidos
ES2734364T3 (es) Agente preventivo y/o terapéutico para enfermedades inmunitarias
ES2334747B2 (es) Nuevas (rs)- 7- o 9- (1,2,3,5- tetrahidro-4,1-benzocazepin-3-il)-7h o9h-purinas con actividad antitumoral.
HK40101420A (en) Imidazoquinoline compounds and uses thereof